查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827384

醫療圖像市場按模式、組件、應用、最終用戶、解剖結構、部署模式和分銷管道分類 - 全球預測 2025-2032

Medical Imaging Market by Modality, Component, Application, End User, Anatomy, Deployment Mode, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療圖像市場規模將成長至 1,880.7 億美元，複合年成長率為 15.06%。

主要市場統計數據
基準年2024年 612.2億美元
預計2025年 704.6億美元
預測年份：2032年 1880.7億美元
複合年成長率（%） 15.06%

不斷發展的醫學影像生態系統的簡明框架，將模式創新、臨床需求和業務需求與策略決策連結起來

醫療圖像影像領域正處於快速技術創新、臨床路徑演變和醫療保健領域營運壓力不斷增加的交匯點。影像擷取、處理演算法和資訊學的進步正在擴展診斷能力，同時也提高了對互通性、資料安全性和工作流程效率的期望。同時，醫療系統對改善療效和控制成本的追求，推動了對具有臨床價值且能夠無縫整合到更廣泛的數位醫療生態系統的影像解決方案的需求。

在此背景下，從製造商到醫院採購團隊的相關人員正在重新調整投資優先順序。供應商正在從單一產品策略轉向軟體驅動的平台和以服務為中心的模式，以支援生命週期價值和經常性收益。臨床醫生越來越依賴多模態影像來指南診斷和治療，這使得特定模態的優勢和跨模態整合的重要性日益凸顯。因此，決策者不僅要考慮技術性能，還要考慮供應鏈的彈性、法規遵循以及採用先進影像處理工具對員工的影響。

以下章節總結了模態創新、組件生態系統、特定應用要求、最終用戶動態、解剖重點領域、部署偏好和分銷方法如何塑造整個醫療圖像價值鏈中組織的策略機會和營運風險。

不斷發展的模式、人工智慧軟體、整合服務和混合分銷模式如何重新定義競爭優勢和臨床採用動態

關鍵的顛覆性力量正在重塑影像技術的開發、部署和消費方式，這些轉變要求製造商、供應商和支付者積極適應。人工智慧和先進的影像分析技術正在加速診斷吞吐量並增強臨床解讀，從而改變人們對本地和雲端部署的軟體和資料管理的期望。同時，硬體技術的進步也不斷提升解析度和功能洞察力，從錐狀射束CT、PET-CT混合掃描和光譜成像等電腦斷層掃描技術的進步，到磁振造影和不斷擴展的光學成像模式。

同時，核子醫學影像，包括正子斷層掃描和單光子放射電腦斷層掃描 (SEM)，在代謝和分子評估中保持著重要性，推動著專門的臨床通訊協定。超音波和 X 光對於即時診斷和常規診斷仍然至關重要，促使製造商投資於便攜性和方便用戶使用介面。組件生態系統正在轉向提供可衡量價值的整合產品：硬體、軟體和安裝、維護和有針對性的培訓等服務。此外，將直接銷售與經銷商和線上零售商）結合的分銷策略正在最佳化覆蓋範圍和售後支援。從醫院和影像中心到診所和門診手術中心的最終用戶都需要彈性價格設定和部署選項。因此，公司必須制定將模態優勢與心臟病學、腫瘤學和神經病學等應用領域相結合的策略；考慮從心血管到兒科成像的解剖重點；並平衡雲分析與內部控制以實現臨床、安全和營運目標。

評估新的關稅政策將如何造成供應鏈複雜性、推動區域製造業轉變以及改變耐用成像技術的採購重點

2025年關稅和貿易措施的實施將對整個醫療圖像供應鏈產生連鎖反應，影響採購選擇、採購週期和供應商關係。先前依賴跨境進口零件和成品的供應商正面臨投入成本上升和前置作業時間延長的問題，促使客戶和製造商重新評估籌資策略。為此，一些製造商加快了區域製造和組裝，以減輕關稅的影響；而另一些製造商則重新協商了供應商合約或尋求其他物流路線，以維持交貨時間和利潤結構。

因此，醫療系統和影像服務提供者正在重新評估其資本採購優先順序和服務契約，優先考慮總體擁有成本和長期可維護性，而非短期降價。關稅也引發了關於供應商多元化的討論，採購團隊正在探索多源採購方案，以降低集中度風險。此外，與跨境貿易相關的監管合規性和文件要求增加了行政管理的複雜性，並影響了安裝和整合服務的前置作業時間。重要的是，這些發展趨勢凸顯了售後服務和本地支援的策略重要性。服務提供者高度重視可靠的維護、快速的備件供應以及供應商的應對力，以維持臨床運作。

展望未來，貿易政策的累積影響正推動相關人員投資於供應鏈透明度、情境規劃以及明確應對關稅意外事件的合約條款。同時，製造商正在評估產品重新設計和模組化方法，以實現高價值部件的本地化，並減輕關稅的影響，從而在保持臨床性能和安全標準的同時保持競爭力。

從細分觀點揭示了醫療模式能力、軟體和服務生態系統以及實施偏好如何相互作用，從而決定臨床和商業性的成功

檢驗細分市場的動態變化，可以發現不同設備、組件、應用、最終用戶、解剖重點領域、部署模式和分銷管道之間存在的差異化商業機會和挑戰。包括錐狀射束CT、PET-CT 和能譜 CT 在內的電腦斷層掃描 (CT) 因其速度快、多能量成像清晰，診斷準確，持續吸引投資；而磁共振系統則因其軟組織對比度高、序列先進，有助於製定治療決策，推動需求成長；核醫學成像設備在分子診斷中發揮著關鍵作用，尤其在腫瘤學和超音波斷層掃描領域，發射單極掃描 (PEP) 和單發射斷層掃描 (SEP)尤為重要；而光學成像和超音波診斷的應用範圍正在拓展，涵蓋術中引導和照護現場診斷。 X 光透視系統在急診醫學和常規護理等所有環境中都發揮著重要作用，數位化升級可改善工作流程和影像品質。

從組件角度來看，硬體仍然是成像性能的基礎，但軟體和服務正日益推動差異化。包含安裝和整合、強大的維護和支援以及以臨床醫生為中心的培訓和教育在內的服務包，能夠加快臨床應用速度並延長正常執行時間。心臟病學和腫瘤學需要高解析度、高度可重複的通訊協定和高級分析，而產科、整形外科和小兒科強調患者舒適度、劑量最佳化和量身定做的工作流程解決方案。醫院和診斷成像中心等最終用戶優先考慮擴充性、認證支援和全面的服務契約，而診所和門診手術中心通常重視緊湊的外形規格、經濟高效的部署模型和簡化的維護。

從心血管和腦部影像到乳房和脊柱，解剖學重點領域決定了設備規格、影像通訊協定和報告工具。雲端或本地部署的選擇取決於資料管治、延遲要求和組織的IT策略，而將直銷與經銷商、經銷商和線上零售商等間接通路結合的分銷方式則會影響市場覆蓋範圍和售後響應能力。這些細分洞察相結合，揭示了成功的策略需要整合針對特定模態的創新、軟體支援的工作流程以及針對臨床應用和護理環境的獨特需求而客製化的服務主導支援。

基礎設施、報銷、監管方式和製造能力的區域模式將決定差異化的採用路徑和打入市場策略

區域動態揭示了基礎設施成熟度、報銷環境、法律規範和製造佈局如何影響採用軌跡和戰略重點。在美洲，資本投資能力、先進的醫院網路和成熟的監管途徑正在推動高階醫療設備及分析主導解決方案的快速普及，同時支持強大的售後模式。過渡性資金籌措機制和私營部門的創新正在促進夥伴關係，從而加速新興影像技術的臨床整合。

在歐洲、中東和非洲，多元化的醫療保健系統和多樣化的報銷方式正在形成獨特的需求模式。一些市場優先考慮經濟高效的可攜式成像解決方案以擴大診斷範圍，而其他市場則強調高精度成像模式與先進數據管理相結合，以支援複雜的臨床路徑。監管協調工作和區域合作影響跨境採購和供應鏈規劃。同時，亞太地區都市區地區正在採用先進技術，而醫療資源匱乏地區對可擴展、可攜式遠端成像的需求也不斷成長。快速擴張的醫院基礎設施、不斷成長的本地製造能力以及政府對醫療技術的策略性投資，正在推動全部區域供應商策略和夥伴關係關係的動態發展。

鑑於這些地區差異，供應商和提供者必須根據當地的臨床需求、監管要求和採購慣例產品系列、服務產品和銷售模式，並利用製造地、遠端醫療網路和官民合作關係關係等當地優勢來最佳化存取和營運彈性。

領先公司如何結合收購、人工智慧夥伴關係、社區服務和靈活分銷來建立有彈性的投資組合併擴大臨床覆蓋範圍

產品創新、策略夥伴關係、售後服務以及對軟體和數據能力的定向投資正在塑造醫療圖像的競爭格局。領先的公司正在透過收購、與人工智慧專家合作以及與臨床研究中心合作來擴展其產品組合，以檢驗新的應用並加快監管核准。這些努力旨在創建一個整合的生態系統，將模態硬體、分析主導的軟體和全面的服務相結合，以減少部署阻力並提升生命週期價值。

同時，專注於可攜式超音波、頻譜CT 增強和雲端原生影像管理等利基領域的專業供應商的出現，迫使大型現有企業採用靈活的夥伴關係模式。差異化的售後服務，包括快速安裝、預防性保養、備件物流和臨床醫生培訓，可以成為競爭優勢，尤其是在供應鏈不確定性放大本地化支援價值的情況下。此外，結合與大型醫療系統的直接接觸以及將覆蓋範圍擴大到門診和診所的間接管道的分銷策略，使公司能夠最佳化其覆蓋範圍和應對力。隨著相關人員優先考慮互通性和開放式架構，投資於基於標準的整合和開發者生態系統的公司將處於有利地位，能夠獲取長期價值並擴展到相鄰的數位健康領域。

實用、多管齊下的策略方案，將產品模組化、軟體和服務、供應鏈彈性以及區域上市執行結合起來，以獲得永續優勢

產業領導者必須採取務實、多層面的策略，抓住機遇，同時降低營運和政策風險。首先，優先考慮產品模組化和在地化設計，降低關稅主導的成本波動風險，並實現在各地區的快速組裝和配置。其次，增加對軟體和服務的投資，提升硬體的價值——尤其是人工智慧分析、雲端或混合數據管理以及針對臨床醫生的培訓——以創造經常性收益流並提高員工留存率。第三，透過多方採購、關鍵零件的策略性庫存緩衝以及應對貿易突發事件的合約保護措施，提高供應鏈透明度。

同時，我們根據區域差異客製化市場進入策略，將定價和銷售模式與當地採購慣例和最終用戶能力相結合，同時確保強大的售後市場影響力，確保運作和零件供應。我們與系統整合商、臨床網路和技術供應商建立策略夥伴關係，以增強互通性並加速臨床檢驗。最後，我們將資料管治、網路安全和法規遵循融入產品開發和服務交付中，以滿足醫療保健提供者的期望並加速採購決策。這些措施的結合使組織能夠保持競爭力，支持臨床應用，並適應快速發展的政策和技術環境。

證據主導的調查方法結合了專家訪談、系統性文獻分析、情境評估和交叉檢驗，以確保嚴謹且可行的見解

調查方法整合了原廠藥和二手資料，以建立強力的依證，並透過相關人員三​​角測量檢驗主題研究結果。原廠藥物包括與臨床負責人、採購專業人員、影像技術人員以及製造商和經銷商高管進行結構化訪談和專家諮詢，從而獲得關於營運挑戰、應用促進因素和服務期望的第一手見解。二手資料研究則包括對同儕審查文獻、監管指南、專利申請、公司揭露資訊和技術白皮書的系統性回顧，以繪製技術趨勢和過往研發成果。

基於情境的分析也探討了貿易措施等政策變化對供應鏈和採購行為的影響。為確保嚴謹性，研究結果由獨立專家小組進行交叉檢驗，並與已知的監管和臨床標準進行比對。研究的局限性包括不同地區公開的營運指標存在差異，以及人工智慧和軟體法規的不斷演變，因此需要謹慎地結合具體情況，並對短期影響進行保守的解讀。訪談通訊協定和資料處理均遵循倫理考量，以保護隱私並確保分析的客觀性。

簡潔的綜合，將技術進步、服務主導的差異化和供應鏈彈性結合起來，作為持續採用和價值交付的核心決定因素

總體而言，醫療圖像產業正在經歷一場持續的變革時期，其驅動力來自硬體、分析和服務交付模式的不斷發展，以及政策和採購動態的轉變。特定設備領域的創新不斷擴大診斷和治療能力，但關鍵的差異化因素日益體現在軟體整合、售後服務和供應鏈的適應性。不斷變化的貿易政策正在提昇在地化、模組化設計和多元化採購的重要性，迫使相關人員重新評估其採購框架，並優先考慮全生命週期價值。

展望未來，成功的組織將在核心影像處理能力的投資與戰略性軟體能力、以臨床醫生為中心的培訓計劃以及能夠應對本地差異的彈性分銷和服務網路之間取得平衡。透過使產品設計、商業模式和營運流程與法規環境的實際情況、實施偏好和最終用戶需求相協調，供應商和提供者能夠在保持財務和營運穩定的同時更好地支援臨床結果。最終，有意識地關注互通性、卓越服務和風險管理的供應鏈，將支持醫療機構持續採用和創新。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合人工智慧演算法用於放射學的自動診斷和工作流程最佳化
  • 推出可在患者床邊進行即時診斷的可攜式照護現場影像設備
  • 擴展雲端基礎的PACS 解決方案，實現遠端存取和影像檢查的協作解釋
  • 透過開發結合 PET、MRI 和 CT 的混合多模態影像診斷系統進行全面的疾病評估
  • 實施先進的低劑量 CT通訊協定，在保持影像品質的同時最大限度地減少輻射暴露
  • 整合機器學習模型，用於腫瘤成像的預測分析和個人化治療計劃
  • 擴增實境和全像視覺化工具的出現有助於手術影像和訓練
  • 加強法規和標準化工作，確保醫療圖像資料安全和互通性

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章醫療圖像市場（按模式）

  • 電腦斷層掃描
    • 錐狀射束CT
    • PET-CT
    • 頻譜CT
  • 磁振造影
  • 核子造影
    • 正子斷層掃描
    • 單光子發射電腦斷層掃描
  • 光學成像
  • 超音波
  • X光

第9章醫療圖像市場（按組件）

  • 硬體
  • 服務
    • 安裝和整合
    • 維護和支援
    • 培訓和教育
  • 軟體

第 10 章醫療圖像市場（按應用）

  • 心臟病學
  • 胃腸病學
  • 神經病學
  • 婦產科
  • 腫瘤學
  • 整形外科
  • 泌尿系統

第 11 章醫療圖像市場（按最終用戶）

  • 門診手術中心
  • 診所
  • 診斷影像中心
  • 醫院

第 12 章醫療圖像市場（按解剖學）

  • 腹部
  • 腦
  • 胸部
  • 心血管系統
  • 肌肉骨骼
  • 孩子們
  • 脊椎

第13章醫療圖像市場（依部署模式）

  • 雲
  • 本地部署

第14章醫療圖像市場（按分銷管道）

  • 直銷
  • 間接銷售
    • 經銷商
    • 經銷商
    • 線上零售商

第15章醫療圖像市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章醫療圖像市場：依類別

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國醫療圖像市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Siemens Healthineers AG
    • General Electric Company
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Fujifilm Holdings Corporation
    • Hitachi, Ltd.
    • Shimadzu Corporation
    • Carestream Health, Inc.
    • Samsung Medison Co., Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Product Code: MRR-434CCDA04E90

The Medical Imaging Market is projected to grow by USD 188.07 billion at a CAGR of 15.06% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 61.22 billion
Estimated Year [2025] USD 70.46 billion
Forecast Year [2032] USD 188.07 billion
CAGR (%) 15.06%

A concise framing of the evolving medical imaging ecosystem that links modality innovation, clinical demand, and operational imperatives to strategic decision-making

The medical imaging landscape sits at the intersection of rapid technological innovation, evolving clinical pathways, and intensifying operational pressures across care settings. Advances in image acquisition, processing algorithms, and informatics have expanded diagnostic capabilities while simultaneously raising expectations for interoperability, data security, and workflow efficiency. Meanwhile, health systems pursue improved outcomes and cost management, which amplifies demand for imaging solutions that demonstrate clinical value and seamless integration into broader digital health ecosystems.

Against this backdrop, stakeholders from manufacturers to hospital procurement teams are reassessing investment priorities. Vendors are moving beyond single-product strategies toward software-enabled platforms and service-centric models that support lifecycle value and recurring revenue. Clinicians increasingly rely on multimodal imaging to guide diagnosis and therapy, which elevates the importance of modality-specific strengths and integration across modalities. Consequently, decision-makers must consider not only technology performance but also supply chain resilience, regulatory compliance, and the workforce implications of adopting advanced imaging tools.

In the following sections, the report synthesizes how modality innovation, component ecosystems, application-specific requirements, end-user dynamics, anatomical focus areas, deployment preferences, and distribution approaches collectively shape strategic opportunities and operational risks for organizations across the medical imaging value chain.

How modality advancements, AI-enabled software, integrated services, and hybrid distribution models are collectively redefining competitive advantage and clinical adoption dynamics

Major disruptive forces are reshaping how imaging technologies are developed, deployed, and consumed, and these shifts demand proactive adaptation from manufacturers, providers, and payers alike. Artificial intelligence and advanced image analytics are accelerating diagnostic throughput and augmenting clinical interpretation, which in turn changes expectations for software and data management across on-premise and cloud deployment modes. At the same time, hardware evolution-spanning computed tomography with advances such as cone beam CT, PET-CT hybrids and spectral imaging, to magnetic resonance and expanding optical imaging modalities-continues to enhance resolution and functional insights.

Simultaneously, nuclear imaging retains importance for metabolic and molecular assessments, with positron emission tomography and single photon emission computed tomography driving specialized clinical protocols. Ultrasound and X-ray remain indispensable for point-of-care and routine diagnostics, prompting manufacturers to invest in portability and user-friendly interfaces. Component ecosystems are shifting toward integrated offerings where hardware, software, and services such as installation, maintenance and targeted training converge to deliver measurable value. Furthermore, distribution strategies that blend direct sales with indirect channels including dealers, distributors and online retailers are optimizing reach and aftermarket support, while end users from hospitals and diagnostic imaging centers to clinics and ambulatory surgical centers demand flexible pricing and deployment options. As a result, organizations must craft strategies that align modality strengths with application areas such as cardiology, oncology and neurology, account for anatomical focus from cardiovascular to pediatric imaging, and balance cloud-enabled analytics with on-premise control to meet clinical, security and operational objectives.

Assessing how new tariff policies introduce supply chain complexity, prompt regional manufacturing shifts, and alter procurement priorities for durable imaging technologies

The introduction of tariffs and trade measures in 2025 has reverberated across the medical imaging supply chain, influencing sourcing choices, procurement cycles, and supplier relationships. Suppliers that previously relied on cross-border components and finished equipment imports have faced increased input costs and longer lead times, prompting both customers and manufacturers to reevaluate their procurement strategies. In response, some manufacturers have accelerated regional manufacturing or assembly to mitigate tariff exposure, while others have renegotiated supplier contracts or pursued alternative logistics pathways to preserve delivery schedules and margin structures.

Consequently, health systems and imaging providers have reassessed capital procurement priorities and service agreements, often emphasizing total cost of ownership and long-term serviceability over short-term price reductions. The tariffs have also intensified discussions around vendor diversification, with procurement teams seeking multi-sourced options to reduce concentration risk. Moreover, regulatory compliance and documentation requirements associated with cross-border trade have added administrative complexity, influencing lead times for installation and integration services. Importantly, these dynamics have strengthened the strategic significance of aftermarket services and localized support, as providers place higher value on reliable maintenance, rapid spare parts availability, and vendor responsiveness to sustain clinical operations.

Looking ahead, the cumulative impact of trade policy is encouraging stakeholders to invest in supply chain transparency, scenario planning, and contractual terms that explicitly address tariff contingencies. In parallel, manufacturers are evaluating product redesign and modularization approaches to localize higher-value components and reduce tariff exposure, thereby preserving competitiveness while maintaining clinical performance and safety standards.

Segment-level perspectives that reveal how modality capabilities, software and service ecosystems, and deployment preferences interact to determine clinical and commercial success

Examining segment-level dynamics reveals differentiated opportunities and operational challenges across modalities, components, applications, end users, anatomical focus areas, deployment modes, and distribution channels. Computed tomography, including cone beam CT, PET-CT and spectral CT variants, continues to attract investment where speed and multi-energy imaging deliver diagnostic clarity, while magnetic resonance systems drive demand where soft tissue contrast and advanced sequences inform therapeutic decision-making. Nuclear imaging maintains a crucial role for molecular diagnostics via positron emission tomography and single photon emission computed tomography, especially in oncology and neurology, whereas optical imaging and ultrasound extend diagnostic reach to intraoperative guidance and point-of-care assessment. X-ray systems remain foundational across emergency and routine care settings, benefitting from digital upgrades that enhance workflow and image quality.

From a component perspective, hardware remains fundamental to imaging performance, but software and services increasingly determine differentiation. Service bundles that include installation and integration, robust maintenance and support, and clinician-focused training and education enable faster clinical adoption and higher uptime. Application-driven requirements steer modality selection: cardiology and oncology demand high-resolution, reproducible protocols and advanced analytics, while obstetrics, orthopedics and pediatrics emphasize patient comfort, dose optimization and tailored workflow solutions. End users such as hospitals and diagnostic imaging centers prioritize scalability, accreditation support and comprehensive service agreements, whereas clinics and ambulatory surgical centers often value compact form factors, cost-effective deployment models and simplified maintenance.

Anatomical focus areas-from cardiovascular and brain imaging to breast and spine diagnostics-shape device specifications, imaging protocols and reporting tools. Deployment mode choices between cloud and on-premise arrangements hinge on data governance, latency requirements and institutional IT strategies, and distribution approaches that combine direct sales with indirect channels like dealers, distributors and online retailers influence market reach and aftermarket responsiveness. Collectively, these segmentation insights underscore that winning strategies integrate modality-specific innovation, software-enabled workflows and service-driven support tailored to the unique needs of clinical applications and care settings.

Regional patterns in infrastructure, reimbursement, regulatory approaches, and manufacturing capacity that determine differentiated adoption pathways and go-to-market strategies

Regional dynamics underscore how infrastructure maturity, reimbursement environments, regulatory frameworks, and manufacturing footprints influence adoption trajectories and strategic priorities. In the Americas, capital investment capacity, advanced hospital networks, and established regulatory pathways have fostered rapid uptake of high-end modalities and analytics-driven solutions, while also supporting robust aftermarket service models. Transitional funding mechanisms and private sector innovation encourage partnerships that accelerate clinical integration of emerging imaging technologies.

Across Europe, the Middle East and Africa, heterogeneous healthcare systems and varied reimbursement approaches create differentiated demand patterns; some markets prioritize cost-effective, portable imaging solutions to extend diagnostic reach, while others emphasize high-acuity modalities paired with sophisticated data management to support complex clinical pathways. Regulatory harmonization efforts and regional collaborations influence cross-border procurement and supply chain planning. Meanwhile, Asia-Pacific exhibits a mix of advanced technology adoption in urban centers and growing demand for scalable, portable, and tele-enabled imaging in underserved areas. Rapidly expanding hospital infrastructure, growing local manufacturing capabilities and strategic government investments in health technology drive dynamic vendor strategies and partnerships across the region.

Taken together, these regional distinctions require vendors and providers to calibrate product portfolios, service offerings, and distribution models to local clinical needs, regulatory requirements and procurement practices, while leveraging regional strengths such as manufacturing hubs, telehealth networks, and public-private partnerships to optimize access and operational resilience.

How leading firms are combining acquisitions, AI partnerships, localized services, and flexible distribution to build resilient portfolios and expand clinical reach

Competitive trajectories within the medical imaging landscape are shaped by a mix of product innovation, strategic partnerships, aftermarket services, and targeted investments in software and data capabilities. Leading firms are broadening portfolios through acquisitions, alliances with AI specialists and collaborations with clinical research centers to validate new applications and accelerate regulatory approvals. These efforts aim to create integrated ecosystems that combine modality hardware, analytics-driven software, and comprehensive service offerings that reduce adoption friction and enhance lifecycle value.

At the same time, an emergent cohort of specialized vendors focuses on niche segments such as portable ultrasound, spectral CT enhancements or cloud-native image management, compelling larger incumbents to adopt flexible partnership models. Aftermarket service differentiation-encompassing rapid installation, preventative maintenance, spare parts logistics and clinician training-has become a competitive lever, particularly when supply chain uncertainties amplify the value of localized support. Moreover, distribution strategies that incorporate both direct engagement with large health systems and indirect channels to extend reach into ambulatory care and clinics allow companies to optimize coverage and responsiveness. As stakeholders prioritize interoperability and open architectures, companies that invest in standards-based integration and developer ecosystems are better positioned to capture long-term value and expand into adjacent digital health domains.

A practical, multi-pronged strategic playbook that aligns product modularity, software and services, supply chain resilience, and regional go-to-market execution for sustained advantage

Industry leaders must adopt a pragmatic, multi-dimensional playbook to capitalize on opportunities while mitigating operational and policy risks. First, prioritize product modularity and design for localization to reduce exposure to tariff-driven cost volatility and enable faster regional assembly or configuration. Second, deepen investments in software and services that augment hardware value-particularly AI-enabled analytics, cloud or hybrid data management and clinician-focused training-to create recurring revenue streams and improve retention. Third, strengthen supply chain transparency through multi-sourcing, strategic inventory buffers for critical components, and contractual protections that address trade contingencies.

In parallel, align go-to-market approaches with regional nuances by tailoring pricing and distribution models to local procurement practices and end-user capabilities, while ensuring robust aftermarket arrangements that guarantee uptime and parts availability. Foster strategic partnerships with systems integrators, clinical networks and technology vendors to enhance interoperability and accelerate clinical validation. Finally, embed data governance, cybersecurity and regulatory readiness into product development and service delivery to meet institutional expectations and expedite procurement decisions. Taken together, these actions enable organizations to sustain competitiveness, support clinical adoption, and adapt to a rapidly evolving policy and technology environment.

An evidence-driven methodology combining expert interviews, systematic literature analysis, scenario assessment, and cross-validation to ensure rigorous and actionable insights

The research approach integrated primary and secondary methods to generate a robust evidence base and validate thematic findings through stakeholder triangulation. Primary research comprised structured interviews and expert consultations with clinical leaders, procurement specialists, imaging technologists, and senior executives from manufacturers and distributors, enabling direct insight into operational challenges, adoption drivers, and service expectations. Secondary research involved systematic review of peer-reviewed literature, regulatory guidance, patent filings, company disclosures and technical whitepapers to map technology trends and historical developments.

Data synthesis employed qualitative coding to identify recurring themes and quantitative aggregation where appropriate to describe adoption patterns and service models, while scenario-based analysis explored the implications of policy shifts, such as trade measures, on supply chains and procurement behavior. To ensure rigor, findings were cross-validated with independent expert panels and reconciled against known regulatory and clinical standards. Limitations included variability in publicly available operational metrics across regions and the evolving nature of AI and software regulations, which necessitated careful contextualization and conservative interpretation of near-term implications. Ethical considerations guided interview protocols and data handling to protect confidentiality and ensure objective analysis.

A concise synthesis that connects technology progress, service-driven differentiation, and supply chain resilience as the core determinants of sustained adoption and value delivery

In synthesis, the medical imaging sector is undergoing a sustained period of transformation driven by converging advances in hardware, analytics, and service delivery models alongside shifting policy and procurement dynamics. Modality-specific innovation continues to expand diagnostic and therapeutic capabilities, but the decisive differentiators increasingly reside in software integration, aftermarket services and supply chain adaptability. Trade policy developments have heightened the importance of localization, modular design and diversified sourcing, prompting stakeholders to reassess procurement frameworks and prioritize total lifecycle value.

Going forward, successful organizations will balance investment in core imaging performance with strategic software capabilities, clinician-centered training programs, and resilient distribution and service networks that accommodate regional nuances. By aligning product design, commercial models and operational processes with the realities of regulatory environments, deployment preferences and end-user needs, vendors and providers can better support clinical outcomes while preserving financial and operational stability. Ultimately, a deliberate focus on interoperability, service excellence and risk-managed supply chains will underpin sustained adoption and innovation across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for automated diagnosis and workflow optimization in radiology
  • 5.2. Adoption of portable and point-of-care imaging devices enabling real-time diagnostics at patient bedside
  • 5.3. Expansion of cloud-based PACS solutions for remote access and collaborative interpretation of imaging studies
  • 5.4. Development of hybrid multimodal imaging systems combining PET MRI and CT for comprehensive disease evaluation
  • 5.5. Implementation of advanced low-dose CT protocols to minimize radiation exposure while maintaining image quality
  • 5.6. Integration of machine learning models for predictive analysis and personalized treatment planning in oncology imaging
  • 5.7. Emergence of augmented reality and holographic visualization tools to assist in surgical imaging and training
  • 5.8. Increasing regulatory focus and standardization efforts to ensure data security and interoperability in medical imaging

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Imaging Market, by Modality

  • 8.1. Computed Tomography
    • 8.1.1. Cone Beam CT
    • 8.1.2. PET-CT
    • 8.1.3. Spectral CT
  • 8.2. Magnetic Resonance Imaging
  • 8.3. Nuclear Imaging
    • 8.3.1. Positron Emission Tomography
    • 8.3.2. Single Photon Emission Computed Tomography
  • 8.4. Optical Imaging
  • 8.5. Ultrasound
  • 8.6. X Ray

9. Medical Imaging Market, by Component

  • 9.1. Hardware
  • 9.2. Services
    • 9.2.1. Installation & Integration
    • 9.2.2. Maintenance & Support
    • 9.2.3. Training & Education
  • 9.3. Software

10. Medical Imaging Market, by Application

  • 10.1. Cardiology
  • 10.2. Gastroenterology
  • 10.3. Neurology
  • 10.4. Obstetrics & Gynecology
  • 10.5. Oncology
  • 10.6. Orthopedics
  • 10.7. Urology

11. Medical Imaging Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Imaging Centers
  • 11.4. Hospitals

12. Medical Imaging Market, by Anatomy

  • 12.1. Abdominal
  • 12.2. Brain
  • 12.3. Breast
  • 12.4. Cardiovascular
  • 12.5. Musculoskeletal
  • 12.6. Pediatrics
  • 12.7. Spine

13. Medical Imaging Market, by Deployment Mode

  • 13.1. Cloud
  • 13.2. On Premise

14. Medical Imaging Market, by Distribution Channel

  • 14.1. Direct Sales
  • 14.2. Indirect Sales
    • 14.2.1. Dealers
    • 14.2.2. Distributors
    • 14.2.3. Online Retailers

15. Medical Imaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Medical Imaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Medical Imaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Siemens Healthineers AG
    • 18.3.2. General Electric Company
    • 18.3.3. Koninklijke Philips N.V.
    • 18.3.4. Canon Medical Systems Corporation
    • 18.3.5. Fujifilm Holdings Corporation
    • 18.3.6. Hitachi, Ltd.
    • 18.3.7. Shimadzu Corporation
    • 18.3.8. Carestream Health, Inc.
    • 18.3.9. Samsung Medison Co., Ltd.
    • 18.3.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. MEDICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. MEDICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS MEDICAL IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 317. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2024 (USD MILLION)
  • TABLE 322. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2025-2032 (USD MILLION)
  • TABLE 323. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 324. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 325. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 328. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 335. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 336. LATIN AMERICA MEDICAL IMAGING MARKET SIZE,